:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2150094845-5dd432e447cb49e68e720fe2cf45abdf.jpg)
Key Takeaways
- Morgan Stanley equity strategist Michael Wilson says the surprise trade escalation could kick off “the first meaningful correction” in U.S. stocks since April.
- Healthcare stocks look like the “best hedge” for policy uncertainty, he wrote, while semiconductors, quantum computing and crowded stocks have the most downside risk.
U.S.-China trade tensions are back—and things could get worse for investors before they get better, some on Wall Street say, with the possibility of a big pullback in stocks and a retreat in some hot sectors.
Absent a near-term truce, according to analysts, the bull market that has chugged higher since April could be stopped in its tracks as investors grow wary about how long momentum stocks can keep climbing and harbor anxiety around rich valuations.
Recent market action has already signaled what could come: Gold has climbed, volatility has picked up, and shares of tech stocks like Nvidia (NVDA) and Intel (INTC) have shown vulnerability, dragging on broad market indexes. Still, investors haven’t folded: the S&P 500, the Dow industrials, and the Nasdaq are all still near record levels.
Friday’s trade escalation with China appears to represent the first meaningful decline of this bull run, according to Morgan Stanley equity strategist Michael Wilson. And without a de-escalation in trade tensions between the world’s largest economies, he wrote, stocks could see a decline in the S&P 500 of more than 15%. (The index fell over 11% from April 1, the day before Liberation Day, to its closing low on April 8.)
The best hedges against short-term policy uncertainty, according to Morgan Stanley, is quality—in short, companies with strong fundamental and financial characteristics—and healthcare, the “preferred” defensive sector play. Semiconductors, quantum computing, and crowded stocks that have been climbing higher have the “most downside risk,” he wrote. Given the risk of outsize potential tariffs on China, the firm is underweight on consumer discretionary goods stocks.
Why This Matters to Investors
Trade uncertainty has renewed volatility in U.S. stock markets that have mostly climbed upward for months. There’s no guarantee that the party is over, but some market watchers believe there are good reasons not to consider a timely resolution a sure thing
Ned Davis Research economists “don’t anticipate a quick resolution” after sizing up China’s exports, which continue to climb in the face of high U.S. tariffs.
“China has been able to offset weaker U.S. demand with strong shipments almost everywhere else,” wrote Alejandra Grindal, the firm’s chief global economist, in a recent note. China’s strength could make for lengthier negotiations, she wrote.
The market could withstand a trade escalation, especially if tensions ease in the next few weeks, Morgan Stanley’s Wilson said. But if an additional 100% tariff on China goes effective Nov. 1 without any truce—a bear case—that would negate the firm’s market recovery thesis going into 2026.
The firm’s 12-month price target on the S&P 500 in a bear market is 4,900, more than 25% below current levels; its bull price target is 7,200, an upside of just under 8%.
